-
![N-[2-(2-Amino-6,6-Disubstituted-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-YL)-1,3-Thiazol-4-YL]Amides](/abs-image/US/2017/03/30/US20170088558A1/abs.jpg.150x150.jpg)
1.发明申请公开(公告)号：US20170088558A1
公开(公告)日：2017-03-30
申请号：US15272501
申请日：2016-09-22
Applicant: Pfizer Inc.
Inventor： Michael Aaron Brodney , Christopher Ryan Butler , Lei Zhang , Brian Thomas O'Neill , Patrick Robert Verhoest , Peter Justin Mikochik , John Charles Murray , Xinjun Hou
IPC: C07D513/04 , C07D513/20 , C07D513/10
CPC classification number: C07D513/04 , C07D513/10 , C07D513/20
Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification.Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
![N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides](/abs-image/US/2018/10/30/US10112958B2/abs.jpg.150x150.jpg)
公开(公告)号：US10112958B2
公开(公告)日：2018-10-30
申请号：US15646572
申请日：2017-07-11
Applicant: Pfizer Inc.
Inventor： Michael Aaron Brodney , Christopher Ryan Butler , Lei Zhang , Brian Thomas O'Neill , Patrick Robert Verhoest , Peter Justin Mikochik , John Charles Murray , Xinjun Hou
IPC: C07D513/04 , C07D513/10 , C07D513/20
Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
![N-[2-(2-AMINO-6,6-DISUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL)-1,3-THIAZOL-4-YL] AMIDES](/abs-image/US/2017/10/26/US20170305931A1/abs.jpg.150x150.jpg)
3.发明申请公开(公告)号：US20170305931A1
公开(公告)日：2017-10-26
申请号：US15646572
申请日：2017-07-11
Applicant: Pfizer Inc.
Inventor： Michael Aaron Brodney , Christopher Ryan Butler , Lei Zhang , Brian Thomas O'Neill , Patrick Robert Verhoest , Peter Justin Mikochik , John Charles Murray , Xinjun Hou
IPC: C07D513/04 , C07D513/20 , C07D513/10
CPC classification number: C07D513/04 , C07D513/10 , C07D513/20
Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
![N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides](/abs-image/US/2017/09/05/US09751895B2/abs.jpg.150x150.jpg)
公开(公告)号：US09751895B2
公开(公告)日：2017-09-05
申请号：US15272501
申请日：2016-09-22
Applicant: Pfizer Inc.
Inventor： Michael Aaron Brodney , Christopher Ryan Butler , Lei Zhang , Brian Thomas O'Neill , Patrick Robert Verhoest , Peter Justin Mikochik , John Charles Murray , Xinjun Hou
IPC: C07D513/04 , C07D513/10 , C07D513/20
CPC classification number: C07D513/04 , C07D513/10 , C07D513/20
Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
-
-
Search Results
4
records
(took 0.021 seconds)
